Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Melinta Therapeutics
MLNT

Buy Melinta Therapeutics (MLNT) Stock

MLNT
See MLNT stock price and Buy/Sell Melinta Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
MLNT

Melinta Therapeutics (MLNT)

About Melinta Therapeutics (MLNT)

Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta ...Read more
Market Cap
$1.52M
1 Year High
$8.60
Volume
1 Year Low
$0.06
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch MLNT stock

Melinta Therapeutics Stock News

Melinta Therapeutics stock rating

What analysts recommend for MLNT stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
2.2

Melinta Therapeutics price target

What analysts think MLNT will be worth
Low $0
High $48.75
Current $0
Target $48.75

Melinta Therapeutics earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.7
-1.4
-2.1
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020

Expected EPS
Q4 2020
-$1.75
Actual EPS
Q4 2020

Buy Melinta Therapeutics (MLNT) Stock

MLNT
See MLNT stock price and Buy/Sell Melinta Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch MLNT stock
  • Jynx20 avatar
  • ricofly3 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.